These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22333475)

  • 21. Chronic obstructive pulmonary disease.
    Kerstjens H; Postma D; Ten Hacken N
    Clin Evid; 2004 Jun; (11):2003-30. PubMed ID: 15652094
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease.
    John M; Bosse S; Oltmanns U; Schumacher A; Witt C
    Respir Med; 2005 Nov; 99(11):1418-24. PubMed ID: 15894479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic corticosteroids and COPD exacerbations.
    Mersfelder TL
    Med Health R I; 2005 Aug; 88(8):277-8. PubMed ID: 16273973
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effect of gancao on glucocorticoid receptors in chronic obstructive pulmonary disease].
    Liu T; Wang B; Wang X
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Oct; 22(10):595-7. PubMed ID: 11776547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of inhaled corticosteroids in chronic obstructive pulmonary disease (COPD).
    Med Lett Drugs Ther; 2010 May; 52(1339):41-2. PubMed ID: 20508579
    [No Abstract]   [Full Text] [Related]  

  • 26. Inflammation and remodeling in chronic obstructive pulmonary disease.
    Hamid Q; Cosio M; Lim S
    J Allergy Clin Immunol; 2004 Dec; 114(6):1479-81. PubMed ID: 15577859
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunology of asthma and chronic obstructive pulmonary disease.
    Barnes PJ
    Nat Rev Immunol; 2008 Mar; 8(3):183-92. PubMed ID: 18274560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recommended therapy in chronic obstructive lung disease].
    Magyar P
    Orv Hetil; 2004 Apr; 145(14):777-80. PubMed ID: 15131994
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effects of systemic glucocorticoid hormones on functional indices of the respiratory system in patients with chronic obstructive pulmonary disease during acute phase].
    Komlev AD; Kuziaev AI; Kuzenkova VE; Laskin GM; Kolosova MV
    Ter Arkh; 2007; 79(3):21-5. PubMed ID: 17526190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prognosis for patients with COPD].
    Pneumologie; 2005 May; 59(5):306. PubMed ID: 15902592
    [No Abstract]   [Full Text] [Related]  

  • 31. Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease.
    van Eeden SF; Sin DD
    Respiration; 2008; 75(2):224-38. PubMed ID: 18042978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Global strategy for chronic obstructive pulmonary disease (GOLD). Update for the GOLD recommendations].
    Kroegel C;
    Pneumologie; 2004 Feb; 58(2):65-8. PubMed ID: 14961431
    [No Abstract]   [Full Text] [Related]  

  • 33. Contemporary opinions on administration of inhaled glucocorticosteroids in the treatment of chronic obstructive pulmonary disease.
    Podstawka A; Mosiewicz J; Myśliński W
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):491-7. PubMed ID: 16146136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease.
    Murphy TF
    Curr Opin Infect Dis; 2006 Jun; 19(3):225-30. PubMed ID: 16645482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metalloelastase (MMP-12) induced inflammatory response in mice airways: effects of dexamethasone, rolipram and marimastat.
    Nénan S; Lagente V; Planquois JM; Hitier S; Berna P; Bertrand CP; Boichot E
    Eur J Pharmacol; 2007 Mar; 559(1):75-81. PubMed ID: 17234180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease.
    Adelman A
    J Fam Pract; 1999 Oct; 48(10):750-1. PubMed ID: 12224669
    [No Abstract]   [Full Text] [Related]  

  • 37. Emerging trends in the therapy of COPD: novel anti-inflammatory agents in clinical development.
    Fitzgerald MF; Fox JC
    Drug Discov Today; 2007 Jun; 12(11-12):479-86. PubMed ID: 17532533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats.
    Xu L; Cai BQ; Zhu YJ
    Chin Med J (Engl); 2004 Nov; 117(11):1611-9. PubMed ID: 15569474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of regular inhaled corticosteroid use on chronic obstructive pulmonary disease outcomes.
    Vollmer WM; Peters D; Crane B; Kelleher C; Buist AS
    COPD; 2007 Jun; 4(2):135-42. PubMed ID: 17530507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular and biochemical bases of chronic obstructive pulmonary disease.
    Rufino R; Lapa e Silva JR
    J Bras Pneumol; 2006; 32(3):241-8. PubMed ID: 17273614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.